Why $55 Million Flowed Into a Triple-Leveraged Biotech ETF Worth Less Than $600 Million24/7 Wall Street • 10/20/26
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now24/7 Wall Street • 04/23/26